STAAR SURGICAL CO 8-K

What Happened
On January 6, 2026, STAAR Surgical Company (Nasdaq: STAA) held a special meeting of stockholders to consider proposals related to the Agreement and Plan of Merger dated August 4, 2025, among Alcon Research, LLC, Rascasse Merger Sub, Inc. (a wholly owned Alcon subsidiary) and STAAR. The company filed an Item 8.01 8-K and issued a press release announcing the preliminary voting results of that Special Meeting; the press release is attached as Exhibit 99.1 to the filing. The Merger Agreement has been amended previously (Amendment No. 1 on Nov 7, 2025 and Amendment No. 2 on Dec 9, 2025).

Key Details

• Special meeting held: January 6, 2026.
• Transaction document: Agreement and Plan of Merger dated August 4, 2025 (with Amendments on Nov 7 and Dec 9, 2025).
• Parties: STAAR Surgical Company, Alcon Research, LLC, and Rascasse Merger Sub, Inc.
• Filing: Form 8-K (Item 8.01) disclosing a press release with preliminary voting results (Exhibit 99.1).

Why It Matters
The stockholder vote directly affects whether the proposed merger with Alcon can proceed toward closing. Retail investors should read the attached press release for the preliminary vote counts and watch for follow-up SEC filings (final vote certification, any required consents or closing notices) that will provide definitive outcomes and timing.